- Home
- RLAY vs BWMX Comparison
RLAY vs BWMX Comparison
Compare RLAY & BWMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- BWMX
- Stock Information
- Founded
- RLAY 2015
- BWMX 1995
- Country
- RLAY United States
- BWMX Mexico
- Employees
- RLAY N/A
- BWMX N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- BWMX Catalog/Specialty Distribution
- Sector
- RLAY Health Care
- BWMX Consumer Discretionary
- Exchange
- RLAY Nasdaq
- BWMX Nasdaq
- Market Cap
- RLAY 610.3M
- BWMX 495.6M
- IPO Year
- RLAY 2020
- BWMX N/A
- Fundamental
- Price
- RLAY $3.54
- BWMX $12.94
- Analyst Decision
- RLAY Strong Buy
- BWMX Strong Buy
- Analyst Count
- RLAY 12
- BWMX 1
- Target Price
- RLAY $18.45
- BWMX $22.50
- AVG Volume (30 Days)
- RLAY 2.8M
- BWMX 95.1K
- Earning Date
- RLAY 08-07-2025
- BWMX 07-24-2025
- Dividend Yield
- RLAY N/A
- BWMX 11.07%
- EPS Growth
- RLAY N/A
- BWMX N/A
- EPS
- RLAY N/A
- BWMX 0.84
- Revenue
- RLAY $8,355,000.00
- BWMX $751,432,052.00
- Revenue This Year
- RLAY $17.59
- BWMX $6.54
- Revenue Next Year
- RLAY N/A
- BWMX $6.09
- P/E Ratio
- RLAY N/A
- BWMX $15.38
- Revenue Growth
- RLAY N/A
- BWMX 4.83
- 52 Week Low
- RLAY $1.78
- BWMX $7.00
- 52 Week High
- RLAY $10.72
- BWMX $14.73
- Technical
- Relative Strength Index (RSI)
- RLAY 52.25
- BWMX 62.19
- Support Level
- RLAY $3.31
- BWMX $12.77
- Resistance Level
- RLAY $3.61
- BWMX $13.37
- Average True Range (ATR)
- RLAY 0.21
- BWMX 0.70
- MACD
- RLAY -0.02
- BWMX -0.10
- Stochastic Oscillator
- RLAY 68.67
- BWMX 34.62
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About BWMX Betterware de Mexico S.A.P.I. de C.V.
Betterware de Mexico SAPI de CV is a direct-to-consumer selling company. The company operates through two business segments: the home organization products (Betterware segment or BWM segment) and the beauty and personal care products (B and PC) (JAFRA segment). The Betterware's segment is divided in seven categories of the home organization: Kitchen and food preservation, Home solutions, Bedroom, Bathroom, Laundry & Cleaning, Tech & mobility and wellness. The JAFRA's segment is divided into four categories beauty and personal care: fragrance, color (cosmetics), skin care and toiletries. The company generates a majority of its revenue from the Beauty and personal care (B&PC) (JAFRA segment). Geographically, key revenue for the company is derived from Mexico.